Unichem Laboratories Limited (UNICHEMLAB.BO)
- Previous Close
580.00 - Open
584.70 - Bid 593.25 x --
- Ask 595.40 x --
- Day's Range
584.70 - 599.00 - 52 Week Range
365.35 - 606.85 - Volume
2,104 - Avg. Volume
6,761 - Market Cap (intraday)
41.737B - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
286.38 - EPS (TTM)
2.07 - Earnings Date May 21, 2024 - May 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 1, 2022
- 1y Target Est
355.00
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company also manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
www.unichemlabs.com2,894
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: UNICHEMLAB.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UNICHEMLAB.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UNICHEMLAB.BO
Valuation Measures
Market Cap
41.74B
Enterprise Value
43.97B
Trailing P/E
286.38
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.56
Price/Book (mrq)
1.73
Enterprise Value/Revenue
2.69
Enterprise Value/EBITDA
28.30
Financial Highlights
Profitability and Income Statement
Profit Margin
0.87%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
16.75B
Net Income Avi to Common (ttm)
145.69M
Diluted EPS (ttm)
2.07
Balance Sheet and Cash Flow
Total Cash (mrq)
661.37M
Total Debt/Equity (mrq)
12.05%
Levered Free Cash Flow (ttm)
--
Research Analysis: UNICHEMLAB.BO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: UNICHEMLAB.BO
UNICHEMLAB.BO does not have Company Insights